Industry Research Reports

Home > Reports > Chemical & Material > Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-15

Pages: 99 Pages

Report ld: 3959938

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Lenalidomide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.

North American market for Lenalidomide API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lenalidomide API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Lenalidomide API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Lenalidomide API include Dr. Reddy’s Laboratories Ltd., Johnson Matthey PLC, Changzhou Pharmaceutical Factory, Shilpa Medicare Limited, Biocon Limited, Sun Pharmaceutical Industries Ltd., Shenzhen Haorui, Mac-Chem Products (India) Pvt.Ltd, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Lenalidomide API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lenalidomide API by region & country, by Type, and by Application.

The Lenalidomide API market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lenalidomide API.

MARKET SEGMENTATION

By Company

Dr. Reddy’s Laboratories Ltd.
Johnson Matthey PLC
Changzhou Pharmaceutical Factory
Shilpa Medicare Limited
Biocon Limited
Sun Pharmaceutical Industries Ltd.
Shenzhen Haorui
Mac-Chem Products (India) Pvt.Ltd

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity≥98%
Purity<98%

Segment by Application

Lenalidomide capsules
Others

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Lenalidomide API Product Introduction

1.2 Global Lenalidomide API Market Size Forecast

1.2.1 Global Lenalidomide API Sales Value (2020-2031)

1.2.2 Global Lenalidomide API Sales Volume (2020-2031)

1.2.3 Global Lenalidomide API Sales Price (2020-2031)

1.3 Lenalidomide API Market Trends & Drivers

1.3.1 Lenalidomide API Industry Trends

1.3.2 Lenalidomide API Market Drivers & Opportunity

1.3.3 Lenalidomide API Market Challenges

1.3.4 Lenalidomide API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Lenalidomide API Players Revenue Ranking (2024)

2.2 Global Lenalidomide API Revenue by Company (2020-2025)

2.3 Global Lenalidomide API Players Sales Volume Ranking (2024)

2.4 Global Lenalidomide API Sales Volume by Company Players (2020-2025)

2.5 Global Lenalidomide API Average Price by Company (2020-2025)

2.6 Key Manufacturers Lenalidomide API Manufacturing Base and Headquarters

2.7 Key Manufacturers Lenalidomide API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Lenalidomide API

2.9 Lenalidomide API Market Competitive Analysis

2.9.1 Lenalidomide API Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Lenalidomide API Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lenalidomide API as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Purity≥98%

3.1.2 Purity

TABLE OF FIGURES

List of Tables

Table 1. Lenalidomide API Market Trends

Table 2. Lenalidomide API Market Drivers & Opportunity

Table 3. Lenalidomide API Market Challenges

Table 4. Lenalidomide API Market Restraints

Table 5. Global Lenalidomide API Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Lenalidomide API Revenue Market Share by Company (2020-2025)

Table 7. Global Lenalidomide API Sales Volume by Company (2020-2025) & (Ton)

Table 8. Global Lenalidomide API Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Lenalidomide API Price by Company (2020-2025) & (US$/Ton)

Table 10. Key Manufacturers Lenalidomide API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Lenalidomide API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Lenalidomide API

Table 13. Global Lenalidomide API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lenalidomide API as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Lenalidomide API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Lenalidomide API Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Lenalidomide API Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Lenalidomide API Sales Market Share in Value by Type (2020-2025)

Table 20. Global Lenalidomide API Sales Market Share in Value by Type (2026-2031)

Table 21. Global Lenalidomide API Sales Volume by Type: 2020 VS 2024 VS 2031 (Ton)

Table 22. Global Lenalidomide API Sales Volume by Type (2020-2025) & (Ton)

Table 23. Global Lenalidomide API Sales Volume by Type (2026-2031) & (Ton)

Table 24. Global Lenalidomide API Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Lenalidomide API Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Lenalidomide API Price by Type (2020-2025) & (US$/Ton)

Table 27. Global Lenalidomide API Price by Type (2026-2031) & (US$/Ton)

Table 28. Global Lenalidomide API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Lenalidomide API Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Lenalidomide API Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Lenalidomide API Sales Market Share in Value by Application (2020-2025)

Table 32. Global Lenalidomide API Sales Market Share in Value by Application (2026-2031)

Table 33. Global Lenalidomide API Sales Volume by Application: 2020 VS 2024 VS 2031 (Ton)

Table 34. Global Lenalidomide API Sales Volume by Application (2020-2025) & (Ton)

Table 35. Global Lenalidomide API Sales Volume by Application (2026-2031) & (Ton)

Table 36. Global Lenalidomide API Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Lenalidomide API Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Lenalidomide API Price by Application (2020-2025) & (US$/Ton)

Table 39. Global Lenalidomide API Price by Application (2026-2031) & (US$/Ton)

Table 40. Global Lenalidomide API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Lenalidomide API Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Lenalidomide API Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Lenalidomide API Sales Value by Region (2020-2025) & (%)

Table 44. Global Lenalidomide API Sales Value by Region (2026-2031) & (%)

Table 45. Global Lenalidomide API Sales Volume by Region (Ton): 2020 VS 2024 VS 2031

Table 46. Global Lenalidomide API Sales Volume by Region (2020-2025) & (Ton)

Table 47. Global Lenalidomide API Sales Volume by Region (2026-2031) & (Ton)

Table 48. Global Lenalidomide API Sales Volume by Region (2020-2025) & (%)

Table 49. Global Lenalidomide API Sales Volume by Region (2026-2031) & (%)

Table 50. Global Lenalidomide API Average Price by Region (2020-2025) & (US$/Ton)

Table 51. Global Lenalidomide API Average Price by Region (2026-2031) & (US$/Ton)

Table 52. Key Countries/Regions Lenalidomide API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Lenalidomide API Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Lenalidomide API Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Lenalidomide API Sales Volume, (2020-2025) & (Ton)

Table 56. Key Countries/Regions Lenalidomide API Sales Volume, (2026-2031) & (Ton)

Table 57. Dr. Reddy’s Laboratories Ltd. Company Information

Table 58. Dr. Reddy’s Laboratories Ltd. Introduction and Business Overview

Table 59. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 60. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Product Offerings

Table 61. Dr. Reddy’s Laboratories Ltd. Recent Development

Table 62. Johnson Matthey PLC Company Information

Table 63. Johnson Matthey PLC Introduction and Business Overview

Table 64. Johnson Matthey PLC Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 65. Johnson Matthey PLC Lenalidomide API Product Offerings

Table 66. Johnson Matthey PLC Recent Development

Table 67. Changzhou Pharmaceutical Factory Company Information

Table 68. Changzhou Pharmaceutical Factory Introduction and Business Overview

Table 69. Changzhou Pharmaceutical Factory Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 70. Changzhou Pharmaceutical Factory Lenalidomide API Product Offerings

Table 71. Changzhou Pharmaceutical Factory Recent Development

Table 72. Shilpa Medicare Limited Company Information

Table 73. Shilpa Medicare Limited Introduction and Business Overview

Table 74. Shilpa Medicare Limited Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Shilpa Medicare Limited Lenalidomide API Product Offerings

Table 76. Shilpa Medicare Limited Recent Development

Table 77. Biocon Limited Company Information

Table 78. Biocon Limited Introduction and Business Overview

Table 79. Biocon Limited Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 80. Biocon Limited Lenalidomide API Product Offerings

Table 81. Biocon Limited Recent Development

Table 82. Sun Pharmaceutical Industries Ltd. Company Information

Table 83. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview

Table 84. Sun Pharmaceutical Industries Ltd. Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 85. Sun Pharmaceutical Industries Ltd. Lenalidomide API Product Offerings

Table 86. Sun Pharmaceutical Industries Ltd. Recent Development

Table 87. Shenzhen Haorui Company Information

Table 88. Shenzhen Haorui Introduction and Business Overview

Table 89. Shenzhen Haorui Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 90. Shenzhen Haorui Lenalidomide API Product Offerings

Table 91. Shenzhen Haorui Recent Development

Table 92. Mac-Chem Products (India) Pvt.Ltd Company Information

Table 93. Mac-Chem Products (India) Pvt.Ltd Introduction and Business Overview

Table 94. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 95. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Product Offerings

Table 96. Mac-Chem Products (India) Pvt.Ltd Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Lenalidomide API Downstream Customers

Table 100. Lenalidomide API Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Lenalidomide API Product Picture

Figure 2. Global Lenalidomide API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Lenalidomide API Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Lenalidomide API Sales Volume (2020-2031) & (Ton)

Figure 5. Global Lenalidomide API Sales Price (2020-2031) & (US$/Ton)

Figure 6. Lenalidomide API Report Years Considered

Figure 7. Global Lenalidomide API Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Lenalidomide API Players Sales Volume Ranking (2024) & (Ton)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Lenalidomide API Revenue in 2024

Figure 10. Lenalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Purity≥98% Picture

Figure 12. Purity

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Lenalidomide API market? zhanKai

The top companies in the global Lenalidomide API market are Dr. Reddy’s Laboratories Ltd.、Johnson Matthey PLC、Changzhou Pharmaceutical Factory.

Related Reports

Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 126
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2026
The global Lenalidomide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 139
USD 4900.00
(Single User License)
Global Lenalidomide API Market Research Report 2025
The global market for Lenalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 95
USD 2900.00
(Single User License)
Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 77
USD 4250.00
(Single User License)
Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-04-15
Pages: 95
USD 4900.00
(Single User License)
Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-02-23
Pages: 97
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2024
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-01-10
Pages: 85
USD 2900.00
(Single User License)

Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 126
USD 3950.00 (Single User License)
Global Lenalidomide API Market Research Report 2026
The global Lenalidomide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
USD 2900.00 (Single User License)
Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 139
USD 4900.00 (Single User License)
Global Lenalidomide API Market Research Report 2025
The global market for Lenalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 95
USD 2900.00 (Single User License)
Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 77
USD 4250.00 (Single User License)
Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-04-15
Pages: 95
USD 4900.00 (Single User License)
Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-02-23
Pages: 97
USD 3950.00 (Single User License)
Global Lenalidomide API Market Research Report 2024
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-01-10
Pages: 85
USD 2900.00 (Single User License)